Loading...
Summary: The law firm of Hogan Lovells announced on Monday morning that Heidi Gertner has joined the firm from the Food and Drug Administration.
The law firm of Hogan Lovells has announced via a press release that Heidi Gertner has joined the firm as a partner. Gertner will work in the Government Regulatory practice as part of the Pharmaceutical and Biotechnology practice group.
Gertner joins the firm from the Office of the Chief Counsel of the United States Food and Drug Administration. She served as the Senior Counsel to the Center for Drug Evaluation and Research.
To read more about Hogan Lovells, click here.
Gertner also worked as the leader of the OTC Drugs Team and FDAAA Safety Team. Gertner spent 13 years with the FDA.
Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!
“Heidi’s experience with issues that our clients confront every day is exactly what we need to continue expanding our thriving practice,” said Meredith Manning, co-director of Hogan Lovells’ Pharmaceutical and Biotechnology practice group.
The practice group co-director, Philip Katz, said, “The knowledge she has from 13 years at FDA – not just about the law, but about FDA policies, priorities, and practices – will allow Heidi to join us in providing creative, practical advice to help clients successfully conduct their business, which is what we do.”
Gertner has completed post-doctoral fellowships in bioethics at the National Institutes of Health and the Cleveland Clinic Foundation.
To read more about the FDA, click here.
She has also served as a visiting assistant professor of bioethics at the law and medical schools for Case Western Reserve University. Gertner is an adjunct professor at American University’s Washington College of Law right now.
“I am eager to become part of Hogan Lovells,” said Gertner. “I look forward to helping the firm continue building and growing its leading drug regulatory practice.”
Gertner earned her law degree from Washington University School of Law.
What type of impact will the addition of Gertner have on the firm? Share your thoughts in our poll below.
Loading ...Image credit: Hogan Lovells
